Research Output per year
Research Output per year
Personal profile
Research interests
Our group is interested in deciphering the molecular response mechanisms to clinical schedules of fractionated radiotherapy. The overarching goal is to understand how tumor cells and the tumor micro-environment respond to different schedules of fractionated radiotherapy in order to optimize dose-scheduling of combination therapies.
Over the last decade, we have used different approaches to determine the role of the tumor microenvironment in the response to radiotherapy and to monitor the cellular response(s) of the tumor microenvironment to radiotherapy. This includes studies in cultured cell in vitro, in tumor models in vivo as well as in tumor tissues derived from cancer patients.
Specialisation
Angiogenesis
Radiobiology
Molecular Cell Biology
Glycobiology
External positions
Postdoc, Maastricht UMC
2002 → 2009PhD student, Maastricht UMC
1997 → 2002Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
-
Combining Radiation Therapy With Interferons: Back to the Future
Goedegebuure, R. S. A., Vonk, C., Kooij, L. P., Derks, S. & Thijssen, V. L. J. L., 1 Sep 2020, In : International Journal of Radiation Oncology Biology Physics. 108, 1, 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Development of transient radioresistance during fractionated irradiation in vitro
van den Berg, J., Castricum, K. C. M., Meel, M. H., Goedegebuure, R. S. A., Lagerwaard, F. J., Slotman, B. J., Hulleman, E. & Thijssen, V. L. J. L., Jul 2020, In : Radiotherapy and Oncology. 148, p. 107-114 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Goedegebuure, R. S. A., de Klerk, L. K., Bass, A. J., Derks, S. & Thijssen, V. L. J. L., 2019, In : Frontiers in Immunology. 10, JAN, 3107.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access -
Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts
Muller, J., Duray, E., Lejeune, M., Dubois, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V. L., Beguin, Y., Heusschen, R. & Caers, J., 1 Feb 2019, In : Cancers. 11, 2, 261.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Targeting tumor vascular CD99 inhibits tumor growth
Huijbers, E. J. M., Van Der Werf, I. M., Faber, L. D., Sialino, L. D., Van Der Laan, P., Holland, H. A., Cimpean, A. M., Thijssen, V. L. J. L., Van Beijnum, J. R. & Griffioen, A. W., 2019, In : Frontiers in Immunology. 10, APR, 651.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
Activities
- 4 Examination
-
Tumor-associated glycan structures: friend or foe in immunity to cancer?
Victor Thijssen (Examiner)
2 Jul 2019Activity: Examination
-
Platelets and Platelet Extracellular Vesicles as Messengers in Vascular Inflammation
Victor Thijssen (Examiner)
9 Nov 2017Activity: Examination
-
-
The IL-17 and Th17 cell immune response in cervical cancer
Victor Thijssen (Examiner)
8 Sep 2015Activity: Examination